LUNDBECK LLC

Lundbeck LLC specializes in the manufacturing of pharmaceutical preparations, with a focused expertise in supporting federal healthcare systems through the production and supply of specialized drugs, hematological agents, and related therapeutics. Their technical capabilities encompass compliance with federal pricing regulations, including Public Law pricing frameworks, and the maintenance of Federal Supply Schedule (FSS) contracts for pharmaceutical procurement. The company demonstrates deep familiarity with the regulatory and logistical demands of government pharmaceutical distribution, ensuring consistent availability of critical medications under stringent quality and pricing controls. Their operational model emphasizes precision manufacturing, regulatory adherence, and seamless integration with federal supply chains. The Department of Veterans Affairs is the primary federal partner, with whom Lundbeck LLC has established a sustained relationship centered on the provision of pharmaceuticals under FSS contracts and adherence to evolving public law pricing mandates. This indicates a trusted role in supplying VA medical facilities with essential medications, including those used in hematology and complex therapeutic categories, under structured federal procurement mechanisms. The contractor’s industry focus is narrowly aligned with NAICS 325412, which encompasses the formulation, production, and packaging of finished pharmaceutical products for clinical use. This positions Lundbeck LLC as a niche manufacturer serving the government’s specialized drug needs, particularly in areas requiring strict batch control, regulatory documentation, and compliance with federal pricing statutes. Their market presence is defined by reliability in meeting the precise requirements of federal healthcare procurement rather than broad commercial distribution. Lundbeck LLC operates as a 2L entity headquartered in Deerfield, Illinois, with no public certifications listed. The company’s geographic and operational footprint is centered on supporting federal pharmaceutical supply chains, leveraging its manufacturing infrastructure to fulfill government-specific contractual obligations without reliance on small business or minority-owned program designations.